HomeSABS • NASDAQ
add
SAB Biotherapeutics Inc
Nakaraang pagsara
$1.70
Sakop ng araw
$1.64 - $1.70
Sakop ng taon
$1.00 - $5.01
Market cap
15.79M USD
Average na Volume
23.97K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 114.70K | -62.40% |
Gastos sa pagpapatakbo | 2.47M | -83.39% |
Net na kita | -11.39M | 50.15% |
Net profit margin | -9.93K | -32.57% |
Kita sa bawat share | -0.98 | 84.65% |
EBITDA | -9.24M | 48.50% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 20.76M | -63.30% |
Kabuuang asset | 44.20M | -47.35% |
Kabuuang sagutin | 18.23M | -31.59% |
Kabuuang equity | 25.97M | — |
Natitirang share | 9.29M | — |
Presyo para makapag-book | 0.61 | — |
Return on assets | -51.07% | — |
Return on capital | -69.45% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -11.39M | 50.15% |
Cash mula sa mga operasyon | -9.53M | 29.11% |
Cash mula sa pag-invest | 9.33M | 13,849.21% |
Cash mula sa financing | 216.96K | -99.68% |
Net change in cash | -273.21K | -100.50% |
Malayang cash flow | -6.91M | 37.82% |
Tungkol
Itinatag
2014
Headquarters
Website
Mga Empleyado
63
